Niraparib is an Orally Active PARP Inhibitor - Network of Cancer Research
PARP Inhibitors as Initial Treatment for Ovarian Cancer - NCI
![The action and resistance mechanism of PARP inhibitors] The left panel... | Download Scientific Diagram](https://www.researchgate.net/publication/339633665/figure/fig2/AS:864817535516673@1583199976658/The-action-and-resistance-mechanism-of-PARP-inhibitors-The-left-panel-and-right-panel.png "The action and resistance mechanism of PARP inhibitors] The left panel... | Download Scientific Diagram")
The action and resistance mechanism of PARP inhibitors] The left panel... | Download Scientific Diagram
PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions | British Journal of Cancer
Biomedicines | Free Full-Text | Role of PARP in TNBC: Mechanism of Inhibition, Clinical Applications, and Resistance
An Overview of PARP Inhibitors for the Treatment of Breast Cancer | SpringerLink
How Do PARP Inhibitors Work In Cancer? | Dana-Farber Cancer Institute
A decade of clinical development of PARP inhibitors in perspective - Annals of Oncology
Discussion of PARP inhibitors in cancer therapy | Pharmaceutical Patent Analyst
Current Clinical Application and Response Prediction Biomarkers of PARP Inhibitors | Bentham Science
An Overview of PARP Inhibitors for the Treatment of Breast Cancer | SpringerLink
Mechanism of Action of PARP Inhibitors. Note: in the presence of a PARP... | Download Scientific Diagram
PARP inhibitor - Wikipedia
Advances and perspectives of PARP inhibitors | Experimental Hematology & Oncology | Full Text
PARP Inhibition | PARP Inhibitor Review
An update on PARP inhibitors—moving to the adjuvant setting | Nature Reviews Clinical Oncology
PARP Inhibitors: Where Are We in 2020 and What's Coming Next?
PARP inhibitors: the journey from research hypothesis to clinical approval | Personalized Medicine
Unsprung traps keep PARP inhibitors effective | Nature Cell Biology
PARP inhibitors: Clinical utility and possibilities of overcoming resistance - ScienceDirect
The Latest Developments on PARP Inhibitors for Prostate Cancer Treatment
